Immunoadsorption Devices Market: Current Analysis and Forecast (2021-2027)

$3999$7577

Emphasis on Type (Selective, Semi-Selective, Non-Selective, and Others); Product (Toxipak, Pentrasorb CRP, Glycosorb ABO, IgEnio, DALI, Monet, Immunsorba TR, Immunsorba, Therasorb, Selesorb, Oxiris, Cytosorb, Toraymyxin, Seraph, Alteco LPS Adsorber, and others); Therapeutic Area (Cardiology, Neurology, Transplant, Kidney, and Others); and Region and Country

Pages:

273

Table:

36

Figure:

136

Report ID:

UMHE21726

Geography:

Clear
  Get a Free Sample
SKU: UMHE21732 Categories: ,
Report Description
Table of content
Research Methodology

Report Description

Immunoadsorption Devices Market 2
Immunoadsorption Devices Market 2

The global immunoadsorption devices market is expected to showcase significant growth during the forecast period (2021-2027). Immunoadsorption is an extracorporeal technique used for the removal of specific blood group antibodies and molecules from the blood. Currently, a large and different number of devices or columns each with a different active component to which the molecule of interest attaches, thereby allowing for selectivity in the molecules removed. The ability to select a different type of device for different conditions makes the immunoadsorption’s significant advantages over other apheresis techniques, in that it negates the need for replacement of factors such as albumin and plasma. For instance, Pocard’s Toxipak is a selective immunoadsorption device used in sepsis and sepsis shock where another selective immunoadsorption device Gylcosorb ABO is used in ABO compatibility. Rising cases of cardiology, neurology, dermatology, couple with increasing focus on the use of immunoadsorption technique in new areas like sepsis is increasing the demand of immunoadsorption devices.

Insights Presented in the Report

“Amongst type, selective segment held prominent share in the market in 2020.”

Based on type, the market is categorized into selective, semi-selective, non-selective, and others. Among these, selective category held the considerable market share and is expected to continue its performance during the forecast period. This can be attributed to the presence of large number of immunoadsorption devices like Toxipak, Pentrasorb CRP, Miro, Glycosorb ABO, ABO Adsopak, Coraffin, IgEnio, DALI, Monet, and LDL lipopak. Further, selective immunoadsorption device helps in selectively target the molecules without disturbing other molecules, thereby it is commonly used in autoimmune conditions and transplantation.

“Amongst therapeutic area, cardiology segment accounted for major share in the global immunoadsorption devices market

Based on therapeutic area, the market is categorized into cardiology, neurology, transplant, kidney, and others. Among these, cardiology held the considerable share in the market owing to large number of cardiovascular cases. According to World Health Organization (WHO), cardiovascular diseases are the leading cause of death globally. In 2019, representing 32% of all global deaths. Further, increasing geriatric population and changing lifestyle is likely to increase the case in the foreseeable future. This in turn is expected to propel the demand of immunoadsorption devices.

“North America captured significant position in the Immunoadsorption Devices market”

For a better understanding of the market adoption of Immunoadsorption Devices, the market is analyzed based on its worldwide presence in the countries such as North America (United States, Canada, Rest of North America), Europe (Germany, UK, France, Italy, Spain, and Rest of Europe), Asia-Pacific (China, Japan, India, Australia, and Rest of APAC), and Rest of World. North America accounted for significant share in the market and is expected to showcase substantial growth during the forecast period owing developed healthcare infrastructure, large expenditure in the healthcare industry couple with adoption of new technologies in the region.

Reasons to buy this report:

  • The study includes market sizing and forecasting analysis validated by authenticated key industry experts
  • The report presents a quick review of overall industry performance at one glance
  • The report covers in-depth analysis of prominent industry peers with a primary focus on key business financials, product portfolio, expansion strategies, and recent developments
  • Detailed examination of drivers, restraints, key trends, and opportunities prevailing in the industry
  • The study comprehensively covers the market across different segments
  • Deep dive country level analysis of the industry

Customization Options:

The global immunoadsorption devices market can further be customized as per the requirement or any other market segment. Besides this, UMI understands that you may have your own business needs, hence feel free to connect with us to get a report that completely suits your requirements.

You can also purchase parts of this report. Do you want to check out a section wise
price list?

1.1.Market Definitions
1.2.Limitation
1.3.Stake Holders
1.4.Currency used in Report

 

2.1.Research Process of the Immunoadsorption Devices Market
2.2.Research Methodology of the Immunoadsorption Devices Market
2.3.Forecasting Method
2.4.Respondent Profile
2.5.Main Objective of the Immunoadsorption Devices Market Study

 

3MARKET SYNOPSIS

 

4EXECUTIVE SUMMARY

 

5GLOBAL IMMUNOADSORPTION DEVICES MARKET COVID-19 IMPACT

 

6GLOBAL IMMUNOADSORPTION DEVICES MARKET REVENUE (USD MN), 2019-2027F

 

7.1.Selective
7.2.Semi-Selective
7.3.Non-Selective
7.4.Others

 

8.1.Toxipak
8.2.PentraSorb CRP
8.3.Glycosorb ABO
8.4.IgEnio
8.5.DALI
8.6.MONET
8.7.IMMUSORBA TR
8.8.Immunsorba
8.9.TheraSorb
8.10.Selesorb
8.11.Oxiris
8.12.CytoSorb
8.13.Toraymyxin
8.14.Seraph
8.15.Alteco LPS Adsorber
8.16.Others

 

9.1.Cardiology
9.2.Neurology
9.3.Transplant
9.4.Kidney
9.5.Others

 

10.1.North America Immunoadsorption Devices Market 
 10.1.1.United States
 10.1.2.Canada
 10.1.3.Rest of North America
10.2.Europe Immunoadsorption Devices Market 
 10.2.1.Germany
 10.2.2.France
 10.2.3.United Kingdom
 10.2.4.Italy
 10.2.5.Spain
 10.2.6.Rest of Europe
10.3.Asia Pacific Immunoadsorption Devices Market
 10.3.1.China
 10.3.2.Japan
 10.3.3.India
 10.3.4.Australia
 10.3.5.Rest of Asia Pacific
10.4.Rest of World Immunoadsorption Devices Market 

 

11.1.Market Drivers
11.2.Market Challenges
11.3.Impact Analysis

 

12IMMUNOADSORPTION DEVICES MARKET OPPORTUNITIES

 

13IMMUNOADSORPTION DEVICES MARKET TRENDS

 

14LEGAL & REGULATORY FRAMEWORK

 

15.1.Demand Side Analysis
15.2.Supply Side Analysis
 15.2.1.Top Product Launches
 15.2.2.Top Business Partnerships
 15.2.3.Top Business Expansions, Investments and Divestitures
 15.2.4.Top Merger and Acquisitions

 

16VALUE CHAIN ANALYSIS

 

17.1.Competitive Landscape
 17.1.1.Porters Fiver Forces Analysis
  17.1.1.1.Bargaining Power of Buyer
  17.1.1.2.Bargaining Power of Supplier
  17.1.1.3.Intensity of Rivalry
  17.1.1.4.Threats of New Entrant
  17.1.1.5.Threat of Substitute
 17.1.2.Company Shares, by Revenue

 

18.1.Pocard Ltd.
18.2.Pentracor GmbH
18.3.Glycorex Transplantation AB
18.4.Fresenius Medical Care
18.5.Asahi Kasei Medical Device
18.6.Miltenyi Biotec
18.7.Kaneka Medical Product
18.8.Baxter International Inc.
18.9.CytoSorbents Europe GmbH
18.10.Toray Medical Co. Ltd.

 

Note: This is not the exhaustive list, in case of any major player found during the course of study will add in the report

Research Methodology

Analyzing the historical market, estimation of the current market, and forecasting the future market of the Immunoadsorption Devices three major steps undertaken to create and analyze its adoption across the globe. Exhaustive secondary research was conducted to collect the historical market numbers and estimate the current market size. Secondly, to validate these insights, numerous findings and assumptions were taken into consideration. Moreover, exhaustive primary interviews were also conducted, with industry experts across the value chain of the Immunoadsorption Devices industry. Post assumption and validation of market numbers through primary interviews, we employed a bottom-up approach to forecast the complete market size. Thereafter, market breakdown and data triangulation methods were adopted to estimate and analyze the market size of segments and sub-segments the industry pertains to. Detailed methodology is explained below:

Analysis of Historical Market Size

Step 1: In-Depth Study of Secondary Sources:

Detail secondary study was conducted to obtain the historical market size of the Immunoadsorption Devices through company internal sources such as annual report & financial statements, performance presentations, press releases, etc., and external sources including journals, news & articles, government publications, competitor publications, sector reports, third-party database, and other credible publications.

Step 2: Market Segmentation:

After obtaining the historical market size of the Immunoadsorption Devices market, we conducted a detailed secondary analysis to gather current market insights and share for different segments & sub-segments for major regions. Major segment included in the report by type, product, and therapeutic area. Further regional and country-level analyses were conducted to evaluate the overall adoption of the Immunoadsorption Devices globally.

Step 3: Factor Analysis:

After acquiring the historical market size of different segments and sub-segments, we conducted a detailed factor analysis to estimate the current market size of Immunoadsorption Devices. Further, we conducted factor analysis using dependent and independent variables such as growing geriatric population and increasing spending on healthcare sector. A thorough analysis was conducted for demand and supply-side scenario considering increasing investment, top partnerships, merger and acquisition, business expansion, and product launches in the Immunoadsorption Devices industry.

Current Market Size Estimate & Forecast

Current Market Sizing: Based on actionable insights from the above 3 steps, we arrived at the current market size, key players in the global Immunoadsorption Devices market, and market shares of each segment. All the required percentage shares split, and market breakdowns were determined using the above-mentioned secondary approach and were verified through primary interviews.

Estimation & Forecasting: For market estimation and forecast, weights were assigned to different factors including drivers & trends, restraints, and opportunities available for the stakeholders. After analyzing these factors, relevant forecasting techniques i.e., bottom-up approach was applied to arrive at the market forecast to 2027 for different segments and subsegments across the major regions globally. The research methodology adopted to estimate the market size encompasses:

  • The industry’s market size, in terms of value (US$) and the adoption rate of Immunoadsorption Devices across the major markets
  • All percentage shares, splits, and breakdowns of market segments and sub-segments
  • Key players in the Immunoadsorption Devices market. Also, the growth strategies adopted by these players to compete in the fast-growing market.

Market Size and Share Validation

Primary Research: In-depth interviews were conducted with the Key Opinion Leaders (KOLs) including Top Level Executives (CXO/VPs, Sales Head, Marketing Head, Operational Head, and Regional Head, Country Head, etc.) across major regions. Primary research findings were then summarized, and statistical analysis was performed to prove the stated hypothesis. Inputs from primary research were consolidated with secondary findings, hence turning information into actionable insights.

Split of Primary Participants by Stakeholders and Regions

Immunoadsorption Devices Market 1
Immunoadsorption Devices Market 1

Market Engineering

Data triangulation technique was employed to complete the overall market estimation and to arrive at precise statistical numbers of each segment and sub-segment of the global Immunoadsorption Devices market. Data was split into several segments & sub-segments post studying various parameters and trends in the area of type, product, and therapeutic area.

The main objective of the Immunoadsorption Devices market study

The current & future market trends of global Immunoadsorption Devices were pinpointed in the study. Investors can gain strategic insights to base their discretion for investments from the qualitative and quantitative analysis performed in the study. Current and future market trends would determine the overall attractiveness of the market at a country level, providing a platform for the industrial participant to exploit the untapped market to benefit as a first-mover advantage. Other quantitative goals of the studies include:

  • Analyze the current and forecast market size of Immunoadsorption Devices in terms of value (US$). Also, analyze the current and forecast market size of different segments and sub-segments
  • Segment in the study include area of type, product, and therapeutic area
  • Defined analysis of the regulatory framework for the Immunoadsorption Devices industry
  • Analyze the value chain involved with the presence of various intermediaries, along with analyzing customer and competitor behaviors of the industry
  • Analyze the current and forecast market size of the Immunoadsorption Devices for the major countries
  • Major regions/countries analyzed in the report includes North America (US, Canada, Rest of North America), Europe (Germany, UK, France, Italy, Spain, Rest of Europe), Asia-Pacific (China, Japan, India, Australia, Rest of Asia-Pacific), and Rest of World
  • Company profiles of the Immunoadsorption Devices market players and the growth strategies adopted by them to sustain in the growing market
  • Deep dive country level analysis of the industry